CA-ARIBIO-CO.,-LTD.
31.3.2023 18:01:37 CEST | Business Wire | Press release
AriBio Co., Ltd. announced that David Greeley MD, Chief Medical Officer at AriBio, will present biomarker data from the completed phase 2 study in patients with mild to moderate Alzheimer’s disease who were treated with 10mg and 30mg of AR1001. AR1001 is a potent PDE5 inhibitor with preliminary efficacy in cognition, and preclinical effects on neuron apoptosis inhibition, promotion of neurogenesis, increase in neuroplasticity, and stimulation of autophagy to remove toxic proteins.
The phase 2 study was a double-blind, randomized, placebo-controlled, multi-center trial to evaluate the safety and preliminary efficacy of AR1001 over 26 and 52 weeks of treatment in patients with mild to moderate Alzheimer’s disease. The trial enrolled 210 patients at 21 research centers in the United States.
Plasma collected from patients at baseline, week 26 and week 52 was analyzed by Quantarix using the Simoa HD-X analyzer. Meaningful, statistically significant changes were found over 52 weeks of treatment in a post-hoc analysis, including a dose dependent decline of pTau181 at 26 weeks, and further declines after 52 weeks of treatment. Patients randomized to 10 and 30 mg AR1001 treatment after 26 weeks of treatment with placebo also demonstrated similar declines in pTau181. Other plasma markers including NfL, GFAP and AB42/40 ratio were also measured but showed minimal change or no statistical differences over baseline levels.
AriBio initiated a phase 3 pivotal trial with 30mg of AR1001 to be administered daily to early and mild Alzheimer’s disease patients in December of 2022. Enrollment is expected to continue through 2024. “This biomarker data helps bolster the positive effects seen in cognition with the high dose of AR1001 in the Phase 2 study in mild AD patients. We will continue to collect both CSF and plasma as part of the phase 3 study to analyze as supportive data,” stated Dr. Greeley.
About AR1001-ADP3-US01
AR1001-ADP3-US01 (NCT05531526) is a Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease. The study aims to assess the efficacy and safety of AR1001 in slowing the progression of Alzheimer's disease through various cognitive and functional assessments. The details of the clinical trial are available at ClinicalTrials.gov.
About AriBio
AriBio Co., Ltd. is a biopharmaceutical company based in South Korea with offices in the United States. The company focuses on the development of novel therapies for neurodegenerative diseases including Alzheimer’s disease. The company continues to expand its partnerships to accelerate best-in-class treatment options and further advancements in the field of medicine.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230331005009/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hitachi and Google Cloud Expand Strategic Alliance to Accelerate Real-world Deployment of Physical AI Through FDE and Advanced Cybersecurity Solutions9.6.2026 02:20:00 CEST | Press release
Hitachi and Google Cloud will bolster FDE capabilities to accelerate physical AI globally by combining Hitachi’s co-creation approach and digital engineering capabilities cultivated through Lumada with Google Cloud’s advanced AI. Through the development of these FDE capabilities, Hitachi and Google Cloud will enhance HMAX using Gemini Enterprise, helping solve frontline worker challenges through autonomous operations in complex environments. By scaling FDE knowledge, Hitachi will deliver value to a wider range of customers. Expanding the collaboration, Hitachi and Google Cloud will enable customers to bolster their cyber defense capabilities against AI-driven cyber threats. Hitachi, Ltd. (TSE:6501, "Hitachi") today announced the expansion of its strategic alliance*1 with Google Cloud to support customers by accelerating the real-world deployment of physical AI and cybersecurity solutions to protect against AI generated threats. Garnering increasing attention, physical AI is a technolog
VeriSilicon Drives Commercial Adoption of AV2 Across Next-Generation Video and Streaming Applications9.6.2026 02:00:00 CEST | Press release
VC9800D delivers configurable multi-format video processing for AI multimedia, mobile, and smart edge devices VeriSilicon (688521.SH) today announced that its VC9800D Video Processing Unit (VPU) IP supports AV2 decoding, further expanding the company’s advanced video codec portfolio for next-generation video and streaming applications. The VC9800D enables flexible deployment of next-generation video technologies across a broad range of intelligent consumer and multimedia devices. VeriSilicon has released VC9800D with AV2 to multiple global customers and is updating the IP based on the AV2 V1.0 specification. AV2 is the next-generation video coding specification from the Alliance for Open Media (AOMedia). Building on the foundation of AV1, AV2 is engineered to provide superior compression efficiency, enabling high-quality video delivery at significantly lower bitrates. It is optimized for the evolving demands of streaming, broadcasting, and real-time video conferencing. VeriSilicon’s VC
ClickHouse Appoints New Leader for Asia Pacific and Expands Global Go-To-Market Leadership Team9.6.2026 00:45:00 CEST | Press release
Veteran enterprise leaders join across APJ, public sector, financial services, solutions architecture, and revenue operations as the company scales its global organization ClickHouse, a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced a significant expansion of its global go-to-market (GTM) leadership team, headlined by the appointment of Ed Lenta as Vice President, Asia Pacific and Japan (APJ). The additions build on the momentum established last year with the appointment of Kevin Egan as Chief Revenue Officer, and reflect ClickHouse's strategic investment in scaling its global organization to meet surging customer demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260608754768/en/ Ed Lenta, Vice President, Asia Pacific and Japan (APJ), ClickHouse Lenta joins ClickHouse to lead the company's go-to-market efforts across the APJ region. He brings deep experience scaling cloud and
Money20/20 Europe Celebrates Ten Years of Industry Leadership as AI, Digital Assets and Financial Sovereignty Take Centre Stage8.6.2026 17:37:00 CEST | Press release
Money20/20, the world's leading fintech show and the place where money does business, celebrated a major milestone with its 10th Europe edition, convening more than 7,500 attendees, one in three at C-suite level, and over 2,300 companies from over 105 countries in Amsterdam, for three days of industry-defining announcements, strategic partnerships, and dealmaking that set the agenda for the future of financial services. Featuring more than 450 speakers across six stages, Money20/20 Europe welcomed leaders from banking, fintech, payments, policy, technology and digital assets to explore the forces reshaping the future of money. “This year’s show demonstrated that financial services have entered a new phase of transformation,” said Bryony Naylor, Vice President of Money20/20 Europe. “Across the show floor and on stage, we saw leaders move beyond discussing what’s next to actively building it. From AI and digital identity to financial sovereignty and digital assets, the conversations and
Liberty Latin America Selects BTS as Exclusive A2P Messaging Managed Services Partner Across All Its Markets8.6.2026 17:36:00 CEST | Press release
BTS announced today that it has been chosen as the exclusive provider of managed A2P SMS services for Liberty Latin America (LLA), supporting the company’s efforts to strengthen revenue protection, fraud mitigation, traffic intelligence, and operational visibility across its markets. The agreement reinforces LLA’s A2P messaging strategy throughout a broad regional footprint and establishes a coordinated operating model to improve control, visibility, and monetization of A2P traffic across its markets. The partnership will support revenue maximization, stronger fraud protection and grey-route mitigation, enhanced real-time traffic visibility, operational reporting and analytics, revenue assurance, and 24x7x365 managed services support. The agreement spans 25 markets and reflects a high level of operational trust in BTS’ ability to deliver consistent performance across diverse regulatory, technical, and commercial environments. “This agreement gives us a stronger and more consistent oper
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom